Gables Capital Management Inc. Makes New $438,000 Investment in Astera Labs, Inc. $ALAB

Posted by Brian Himes on Jul 12th, 2026

Gables Capital Management Inc. bought a new position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the first quarter, HoldingsChannel.com reports. The fund bought 4,000 shares of the company’s stock, valued at approximately $438,000.

Several other hedge funds have also recently made changes to their positions in the business. Reflection Asset Management purchased a new position in Astera Labs in the fourth quarter worth about $25,000. Smartleaf Asset Management LLC lifted its stake in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Hilltop National Bank lifted its stake in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares during the last quarter. Aventura Private Wealth LLC purchased a new position in shares of Astera Labs in the 4th quarter worth approximately $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in shares of Astera Labs during the 4th quarter valued at approximately $33,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Rothschild & Co Redburn began coverage on Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price target on the stock. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Jefferies Financial Group restated a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Royal Bank Of Canada increased their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Finally, Stifel Nicolaus upped their target price on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $265.75.

View Our Latest Report on Astera Labs

Astera Labs Stock Performance

NASDAQ ALAB traded down $4.48 on Friday, reaching $412.97. 2,158,702 shares of the stock traded hands, compared to its average volume of 5,804,834. The company has a market cap of $70.79 billion, a price-to-earnings ratio of 279.03, a PEG ratio of 4.74 and a beta of 3.66. Astera Labs, Inc. has a 12 month low of $88.18 and a 12 month high of $499.48. The company has a fifty day moving average price of $335.76 and a 200-day moving average price of $214.65.

Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company’s revenue was up 93.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 1.88 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the completion of the transaction, the director directly owned 57,466 shares of the company’s stock, valued at approximately $25,859,700. This represents a 5.75% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,040,691 shares of company stock valued at $507,675,380 over the last three months. Company insiders own 10.40% of the company’s stock.

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.